Myeloablative Haploidentical Transplantation Is Superior to Chemotherapy for Patients With Intermediate-Risk Acute Myelogenous Leukemia in First Complete Remission
Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-1637
Full Text
Open PDFAbstract
Available in full text
Date
November 26, 2018
Authors
Publisher
American Association for Cancer Research (AACR)